USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -4.04 Million USD | -16.94% |
2022 | -3.75 Million USD | -50.02% |
2021 | -2.3 Million USD | -50.02% |
2020 | -1.36 Million USD | 36.9% |
2019 | -1.92 Million USD | 7.55% |
2018 | -2.84 Million CAD | -7.08% |
2017 | -3.16 Million CAD | -33.02% |
2016 | -1.95 Million CAD | -20.9% |
2015 | -1.67 Million CAD | 55.47% |
2014 | -2.75 Million CAD | -394.56% |
2013 | -548.51 Thousand CAD | -563.22% |
2012 | -82.7 Thousand CAD | 28.23% |
2011 | -115.23 Thousand CAD | -1138.72% |
2010 | -9303.00 CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -938.89 Thousand USD | 33.13% |
2023 Q4 | -1.1 Million USD | -70.61% |
2023 Q3 | -648.45 Thousand USD | -25.67% |
2023 Q2 | -515.99 Thousand USD | 42.94% |
2023 Q1 | -904.3 Thousand USD | 14.58% |
2023 FY | - USD | -16.94% |
2022 Q3 | -546.95 Thousand USD | 25.3% |
2022 FY | - USD | -50.02% |
2022 Q4 | -1.05 Million USD | -93.57% |
2022 Q2 | -732.18 Thousand CAD | -68.19% |
2022 Q1 | -435.33 Thousand CAD | 66.5% |
2021 FY | - USD | -50.02% |
2021 Q1 | -128.49 Thousand CAD | 63.05% |
2021 Q3 | -621.84 Thousand CAD | -86.65% |
2021 Q4 | -1.29 Million CAD | -109.0% |
2021 Q2 | -333.16 Thousand CAD | -159.28% |
2020 Q1 | -213.35 Thousand CAD | 74.57% |
2020 Q3 | -425.21 Thousand CAD | -18.08% |
2020 Q4 | -347.79 Thousand CAD | 18.21% |
2020 FY | - USD | 36.9% |
2020 Q2 | -360.12 Thousand CAD | -68.79% |
2019 FY | - USD | 7.55% |
2019 Q4 | -838.89 Thousand CAD | -45.84% |
2019 Q1 | -487.4 Thousand CAD | 41.09% |
2019 Q2 | -597.73 Thousand CAD | -22.64% |
2019 Q3 | -575.2 Thousand CAD | 3.77% |
2018 FY | - CAD | -7.08% |
2018 Q4 | -827.43 Thousand CAD | 16.33% |
2018 Q2 | -550.21 Thousand CAD | -14.76% |
2018 Q3 | -988.9 Thousand CAD | -79.73% |
2018 Q1 | -479.43 Thousand CAD | 62.98% |
2017 Q2 | -622.3 Thousand CAD | -5.83% |
2017 FY | - CAD | -33.02% |
2017 Q4 | -1.29 Million CAD | -104.79% |
2017 Q3 | -632.39 Thousand CAD | -1.62% |
2017 Q1 | -588.04 Thousand CAD | 0.15% |
2016 FY | - CAD | -20.9% |
2016 Q2 | -715.01 Thousand CAD | -71.21% |
2016 Q1 | -417.62 Thousand CAD | 24.91% |
2016 Q4 | -588.93 Thousand CAD | -39.4% |
2016 Q3 | -422.47 Thousand CAD | 40.91% |
2015 FY | - CAD | 55.47% |
2015 Q3 | -378.61 Thousand CAD | -4.37% |
2015 Q2 | -362.75 Thousand CAD | 16.47% |
2015 Q4 | -556.16 Thousand CAD | -46.89% |
2015 Q1 | -434.27 Thousand CAD | -2.31% |
2014 FY | - CAD | -394.56% |
2014 Q4 | -424.48 Thousand CAD | 23.86% |
2014 Q3 | -557.54 Thousand CAD | 63.12% |
2014 Q2 | -1.51 Million CAD | -616.44% |
2014 Q1 | -210.99 Thousand CAD | -410.12% |
2013 FY | - CAD | -563.22% |
2013 Q4 | -41.36 Thousand CAD | 86.87% |
2013 Q2 | -118.41 Thousand CAD | -1124.53% |
2013 Q3 | -314.91 Thousand CAD | -165.95% |
2013 Q1 | -9670.00 CAD | -253.05% |
2012 Q4 | -2739.00 CAD | 85.18% |
2012 Q1 | -29.63 Thousand CAD | -19.68% |
2012 Q2 | -31.85 Thousand CAD | -7.48% |
2012 FY | - CAD | 28.23% |
2012 Q3 | -18.48 Thousand CAD | 41.97% |
2011 Q3 | -51.42 Thousand CAD | -71.42% |
2011 FY | - CAD | -1138.72% |
2011 Q1 | -93.00 CAD | 74.59% |
2011 Q2 | -30 Thousand CAD | -32158.06% |
2011 Q4 | -24.76 Thousand CAD | 51.85% |
2010 FY | - CAD | 0.0% |
2010 Q3 | -92.00 CAD | 0.0% |
2010 Q4 | -366.00 CAD | -297.83% |
2010 Q1 | -9303.00 CAD | 0.0% |
2010 Q2 | -92.00 CAD | 99.01% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Allied Energy Corporation | -279.93 Thousand USD | -1345.876% |
Igene Biotechnology, Inc. | -851.28 Thousand USD | -375.46% |
Lotus Bio-Technology Development Corp. | - USD | Infinity% |
MagIndustries Corp. | -27.23 Million USD | 85.138% |
Itafos Inc. | 53.75 Million USD | 107.53% |
Potash America, Inc. | -317.38 Thousand USD | -1175.294% |
Yara International ASA | 1.45 Billion USD | 100.278% |
Yara International ASA | 1.51 Billion USD | 100.268% |